LT2421539T - Plaučių bakterinės infekcijos gydymo būdai, panaudojant fluorchinolonus - Google Patents

Plaučių bakterinės infekcijos gydymo būdai, panaudojant fluorchinolonus

Info

Publication number
LT2421539T
LT2421539T LT10767800T LT10767800T LT2421539T LT 2421539 T LT2421539 T LT 2421539T LT 10767800 T LT10767800 T LT 10767800T LT 10767800 T LT10767800 T LT 10767800T LT 2421539 T LT2421539 T LT 2421539T
Authority
LT
Lithuania
Prior art keywords
fluoroqinolons
treatment
methods
bacterial infection
lung bacterial
Prior art date
Application number
LT10767800T
Other languages
English (en)
Inventor
Mike Dudley
David Griffith
Olga Rodny
Original Assignee
Horizon Orphan Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43011488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2421539(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Horizon Orphan Llc filed Critical Horizon Orphan Llc
Publication of LT2421539T publication Critical patent/LT2421539T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
LT10767800T 2009-04-24 2010-04-22 Plaučių bakterinės infekcijos gydymo būdai, panaudojant fluorchinolonus LT2421539T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17262509P 2009-04-24 2009-04-24
PCT/US2010/032128 WO2010124141A1 (en) 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoro-quinolones

Publications (1)

Publication Number Publication Date
LT2421539T true LT2421539T (lt) 2019-12-10

Family

ID=43011488

Family Applications (1)

Application Number Title Priority Date Filing Date
LT10767800T LT2421539T (lt) 2009-04-24 2010-04-22 Plaučių bakterinės infekcijos gydymo būdai, panaudojant fluorchinolonus

Country Status (28)

Country Link
US (2) US20120035166A1 (lt)
EP (1) EP2421539B1 (lt)
JP (2) JP6179844B2 (lt)
KR (1) KR20120034626A (lt)
CN (2) CN107050032A (lt)
AU (1) AU2010238765B2 (lt)
BR (1) BRPI1006626B8 (lt)
CA (1) CA2759874C (lt)
CL (1) CL2011002649A1 (lt)
CO (1) CO6450642A2 (lt)
CY (1) CY1122525T1 (lt)
DK (1) DK2421539T3 (lt)
ES (1) ES2755754T3 (lt)
HR (1) HRP20191951T1 (lt)
HU (1) HUE046595T2 (lt)
IL (1) IL215777A (lt)
LT (1) LT2421539T (lt)
MX (1) MX339077B (lt)
MY (1) MY178871A (lt)
NZ (1) NZ596245A (lt)
PL (1) PL2421539T3 (lt)
PT (1) PT2421539T (lt)
RU (1) RU2535056C2 (lt)
SG (3) SG10201403512TA (lt)
SI (1) SI2421539T1 (lt)
SM (1) SMT201900645T1 (lt)
WO (1) WO2010124141A1 (lt)
ZA (1) ZA201107903B (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524735B2 (en) * 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
CA2739897C (en) 2008-10-07 2017-10-03 Mpex Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
DK2473170T3 (da) 2009-09-04 2019-08-12 Horizon Orphan Llc Anvendelse af aerosoliseret levofloxacin til behandling af cystisk fibrose
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
RU2015138796A (ru) * 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
JP6966835B2 (ja) * 2016-02-05 2021-11-17 ホライズン オーファン リミテッド ライアビリティ カンパニー 嚢胞性線維症のためのフルオロキノロン製剤
CN108849939B (zh) * 2018-07-31 2021-02-19 广东省农业科学院植物保护研究所 盐酸左氧氟沙星在制备用于防治烟草青枯病的农药制剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075889A1 (en) 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
RU2255757C1 (ru) * 2004-06-22 2005-07-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Пептидное соединение, восстанавливающее функцию органов дыхания
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
NZ563417A (en) * 2005-05-18 2012-01-12 Mpex Pharmaceuticals Inc Aerosolized fluoroquinolones and uses thereof
KR101621986B1 (ko) * 2008-05-15 2016-05-17 노파르티스 아게 플루오로퀴놀론의 폐 전달
CA2739897C (en) 2008-10-07 2017-10-03 Mpex Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics

Also Published As

Publication number Publication date
CA2759874A1 (en) 2010-10-28
MX339077B (es) 2016-05-10
US20120035166A1 (en) 2012-02-09
PT2421539T (pt) 2019-11-22
HUE046595T2 (hu) 2020-03-30
SG175288A1 (en) 2011-11-28
JP2016053041A (ja) 2016-04-14
IL215777A (en) 2017-09-28
WO2010124141A1 (en) 2010-10-28
HRP20191951T1 (hr) 2021-05-14
RU2011145430A (ru) 2013-05-27
CN107050032A (zh) 2017-08-18
SMT201900645T1 (it) 2020-01-14
JP6179844B2 (ja) 2017-08-16
SI2421539T1 (sl) 2019-12-31
KR20120034626A (ko) 2012-04-12
BRPI1006626B8 (pt) 2021-05-25
JP6228580B2 (ja) 2017-11-08
US20210015811A1 (en) 2021-01-21
ZA201107903B (en) 2013-01-30
EP2421539A1 (en) 2012-02-29
PL2421539T3 (pl) 2020-02-28
CL2011002649A1 (es) 2012-06-22
SG10201811494SA (en) 2019-01-30
MX2011011190A (es) 2012-02-13
EP2421539A4 (en) 2014-01-29
CY1122525T1 (el) 2021-01-27
CA2759874C (en) 2016-11-08
DK2421539T3 (da) 2019-11-18
AU2010238765B2 (en) 2014-12-18
CO6450642A2 (es) 2012-05-31
BRPI1006626A2 (pt) 2020-07-28
MY178871A (en) 2020-10-21
JP2012524811A (ja) 2012-10-18
AU2010238765A1 (en) 2011-11-10
BRPI1006626B1 (pt) 2021-05-11
IL215777A0 (en) 2012-01-31
EP2421539B1 (en) 2019-10-23
NZ596245A (en) 2013-11-29
RU2535056C2 (ru) 2014-12-10
SG10201403512TA (en) 2014-08-28
ES2755754T3 (es) 2020-04-23
CN102427815A (zh) 2012-04-25

Similar Documents

Publication Publication Date Title
LT3251678T (lt) Benzoksaborolo dariniai, skirti bakterinių infekcijų gydymui
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
PL2613774T3 (pl) Kombinacja fenoksybenzaminy i polimyksyny E do leczenia zakażeń drobnoustrojowych
BR112013013584A2 (pt) endoscópio, e, método
ZA201005798B (en) Treatment of microbial infections
BR112012029028A2 (pt) laringoscópio, braços de laringoscópio e métodos de fabricação
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
GB201217097D0 (en) Treatment of bacterial infection
ZA201100616B (en) Treatment of antibiotic-resistant bacteria infection
HUE046595T2 (hu) Eljárások bakteriális tüdõfertõzés kezelésére fluorokinolonok alkalmazásával
BRPI1014767A2 (pt) métodos de tratamento de infecções bacterianas usando oritavancina
EP2563120A4 (en) METHOD, COMPOSITIONS AND KITS FOR PROVIDING THERAPEUTIC TREATMENT
ZA201204249B (en) Treatment of microbial infections
WO2011146624A9 (en) Methods of treating recurring bacterial infection
BRPI1015351A2 (pt) resistência à infecção bacteriana
CY20142200001T2 (el) Αντιβακτηριακος παραγοντας για τη θεραπεια λοιμωδων νοσηματων βακτηριακης προελευσης
FR2941862B1 (fr) Endoprothese tracheale ou tracheobronchique
GB0807781D0 (en) Treatment of bacterial infection
FR2942411B1 (fr) Canule tracheale
CO6811849A2 (es) Tratamiento de infecciones bacterianas
GB0801768D0 (en) Treatment of microbial infections
AU2009900969A0 (en) Treatment of infection
AU2010901811A0 (en) Avian-Based Treatment for Microbial Infection
AU2011901619A0 (en) Avian-Based Treatment for Microbial Infection
TH0901004161A (th) การบำบัดรักษาแบบผสมผสาน สำหรับการรักษาการติดเชื้อ hcv